Evidence map›Paper›PMID 27193828›Full record

ArticleEpidemiology and infection2016

Increasing incidence of Clostridium difficile infections: results from a 5-year retrospective study in a large teaching hospital in the Italian region with the oldest population.

C Alicino, D R Giacobbe, P Durando, D Bellina, A M DI Bella, C Paganino, V Del Bono, C Viscoli, G Icardi, A Orsi

Abstract read
In one paragraph

Article in Epidemiology and infection, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. The Global Burden ofInfectious disease reports · 2025
    Review
  2. Diabetes Mellitus and the Risk and Outcomes ofInfection and drug resistance · 2025
    Review
  3. International journal of molecular sciences · 2023
    Review
  4. Bezlotoxumab in Patients with a PrimaryAntibiotics (Basel, Switzerland) · 2022
    Article
  5. Fidaxomicin for the Treatment ofAntibiotics (Basel, Switzerland) · 2022
    Review
  6. Diagnosing Clostridioides difficile infections with molecular diagnostics: multicenter evaluation of revogene C. difficile assay.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2020
    Article
  7. Molecular Epidemiology and Risk Factors ofFrontiers in cellular and infection microbiology · 2020
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

C AlicinoDepartment of Health Sciences,University of Genoa,Genoa,Italy.
D R GiacobbeDepartment of Health Sciences,University of Genoa,Genoa,Italy.
P DurandoDepartment of Health Sciences,University of Genoa,Genoa,Italy.
D BellinaHygiene and Infection Control Unit,IRCCS University Hospital San Martino-IST National Institute for Cancer Research,Genoa,Italy.
A M DI BellaHygiene and Infection Control Unit,IRCCS University Hospital San Martino-IST National Institute for Cancer Research,Genoa,Italy.
C PaganinoDepartment of Health Sciences,University of Genoa,Genoa,Italy.
V Del BonoInfectious Diseases Unit,IRCCS University Hospital San Martino-IST National Institute for Cancer Research,Genoa,Italy.
C ViscoliDepartment of Health Sciences,University of Genoa,Genoa,Italy.
G IcardiDepartment of Health Sciences,University of Genoa,Genoa,Italy.
A OrsiDepartment of Health Sciences,University of Genoa,Genoa,Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Limited information is available on the incidence of Clostridium difficile infections (CDIs) in Italian hospitals. In this study, we assessed the changes in the incidence of CDI over a 5-year period in a teaching hospital in Liguria, the Italian region with the oldest population. Secondary endpoints were the development of severe CDI and 30-day mortality. The annual incidence of CDI/10000 patient-days significantly increased from 0·54 in 2010 to 3·04 in 2014 (χ 2 for trend, P < 0·001). The median age of patients with CDI was 81 years. As many as 81% and 89% of these patients had comorbid conditions and previous exposure to antibiotics, respectively. In the multivariate analysis of risk factors for severe CDI, previous therapy with histamine 2 blockers and low serum albumin were associated with severe CDI, while diabetes appeared to be protective. In the multivariate model of risk factors for 30-day mortality, high leukocyte count, low serum albumin, and increased serum creatinine were unfavourably associated with outcome. Strict adherence to infection control measures was of utmost importance to counteract the increasing incidence of CDI in our hospital, particularly because of the advanced age of the patients and their very high frequency of chronic conditions and use of antibiotics, which readily predispose them to the development of CDI.

Indexed as

Hospitals, TeachingAgedAged, 80 and overAge FactorsClostridioides difficileClostridium InfectionsFemaleHumansIncidenceItalyMaleMultivariate AnalysisRetrospective StudiesRisk FactorsClostridium difficilehealthcare-associated infectionshospital-acquired infectionsincidencemortality

Identifiers

PMID27193828
PMCPMC9150471

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.